Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brief Report: Psychological Flexibility, Perceived Stress and Emotion Regulation in Transitional-Age Youth (TAY) With Autism Spectrum Disorder (ASD).

Journal of autism and developmental disorders·2026
Same author

Can You See Us Play? Observing Inclusive Outdoor Play Behaviour Among Children With and Without Disabilities: A Mixed Methods Study.

Child: care, health and development·2025
Same author

Play Together? Unveiling Facilitators and Barriers to Inclusive Outdoor Play for Dutch Children With and Without Disabilities: A Qualitative Study.

Child: care, health and development·2025
Same author

Quantitative aortic Na[<sup>18</sup>F]F positron emission tomography computed tomography as a tool to associate vascular calcification with major adverse cardiovascular events.

European journal of nuclear medicine and molecular imaging·2024
Same author

International collaboration in health professions education.

Medical teacher·2024
Same author

Histopathological Features of Monogenic Inflammatory Bowel Disease: Subanalysis of Systematic Review.

Gastro hep advances·2024
Same journal

[Insulin intoxications caused by falsified semaglutide].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Professional skepticism in medical research].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[Improving mobility in painful osteoarthritis].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The effectiveness and costs of the Back At work After Surgery (BAAS) work-integrated care pathway on return to work for patients receiving knee arthroplasty].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[The rise of genetic therapies: urgent moral and societal questions].

Nederlands tijdschrift voor geneeskunde·2026
Same journal

[A man with a wound on his elbow].

Nederlands tijdschrift voor geneeskunde·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.1K

[Variable presentation of giant cell arteritis].

E Brouwer1,2, J van der Laken3, K Visser4

  • 1UMC Groningen, afd. Reumatologie en Klinische Immunologie, Groningen.

Nederlands Tijdschrift Voor Geneeskunde
|November 28, 2024
PubMed
Summary
This summary is machine-generated.

Giant cell arteritis (GCA) is a rare condition affecting those over 50, potentially causing blindness. Prompt diagnosis and treatment are crucial to prevent permanent vision loss.

More Related Videos

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.3K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.5K

Related Experiment Videos

Last Updated: Jun 6, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.1K
A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.3K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.5K

Area of Science:

  • Rheumatology
  • Ophthalmology
  • Vascular Medicine

Background:

  • Giant cell arteritis (GCA) is a vasculitis affecting large arteries, primarily the aorta and its branches.
  • It predominantly impacts individuals over 50 years old and can lead to severe complications like irreversible blindness if not treated promptly.
  • The varied clinical presentation of GCA often complicates early diagnosis.

Observation:

  • This case series highlights diagnostic challenges in recognizing GCA early.
  • It examines the utility and potential delays associated with fast-track clinics for suspected GCA patients.
  • The presentation of two patients with GCA underscores dilemmas in initial management.

Findings:

  • Variable patient presentations can delay the recognition of giant cell arteritis.
  • Timely referral (within 24 hours) to specialized centers with vascular imaging is recommended.
  • Early initiation of prednisolone-sparing agents alongside corticosteroids is a key consideration.

Implications:

  • Improved diagnostic pathways and timely interventions are essential for preventing vision loss in GCA.
  • Fast-track clinics show promise but require optimized protocols for efficient patient management.
  • Further research into optimal treatment strategies, including early steroid-sparing drug use, is warranted to improve patient outcomes.